Art

J-GLOBAL ID：201802281350837186   Reference number：18A0383564

Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group

チロシンキナーゼ阻害剤の時代における治療関連慢性骨髄性白血病の発生率と転帰:CML共同研究グループの調査【Powered by NICT】

Author (14)： Iriyama Noriyoshi (Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Tokuhira Michihide (Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan) ,  Takaku Tomoiku (Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan) ,  Sato Eriko (Division of Hematology, Department of Medicine, Juntendo University Nerima Hospital, Tokyo, Japan) ,  Ishikawa Maho (Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan) ,  Nakazato Tomonori (Department of Hematology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan) ,  Sugimoto Kei-Ji (Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan) ,  Fujita Hiroyuki (Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan) ,  Fujioka Isao (Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan) ,  Hatta Yoshihiro (Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Kizaki Masahiro (Departments of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan) ,  Komatsu Norio (Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan) ,  Asou Norio (Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan) ,  Kawaguchi Tatsuya (Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Kumamoto, Japan)
Material： Leukemia Research  (Leuk Res)
Volume： 54  Page： 55-58  Publication year： 2017 
JST Material Number： T0017A  ISSN： 0145-2126  CODEN： LEREDD  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： This study was performed to in...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0383564&from=J-GLOBAL&jstjournalNo=T0017A") }}

Thesaurus term： hemoglobin ,  *therapy ,  metabasis ,  patient ,  *chronic myeloid leukemia ,  statistics(science)
Semi thesaurus term： 無再発生存率 ,  患者予後 ,  血小板数 ,  慢性期 ,  *転帰 ,  *チロシンキナーゼ阻害剤 , 【Automatic Indexing@JST】

Author keywords (3)： Therapy-related chronic myeloid leukemia ,  Tyrosine kinase inhibitor ,  Prognosis

JST classification (2)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (3)： Dasatinib ,  Nilotinib ,  Imatinib

Terms in the title (10)： チロシンキナーゼ阻害剤 ,  治療 ,  慢性骨髄性白血病 ,  発生率 ,  転帰 ,  CML ,  共同 ,  研究 ,  グループ ,  調査